NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









CARB-X

CARB-X

Boston, Massachusettscarb-x.org

Overview

CARB-X is a global non-profit partnership accelerating antibacterial products to address drug-resistant bacteria, a leading cause of death around the world . CARB-X supports innovative therapeutics, preventatives and rapid diagnostics . It integrates solutions for the prevention, diagnosis, and treatment of life-threatening bacterial infections .

Year Founded

2016

Portfolio Companies

63

Website

carb-x.org

Investments

CARB-X investments
CompanyDateStageLead
AdJaneApr 2026GrantCo-investor
Centauri Therapeutics LimitedFeb 2026Series A ExtensionCo-investor
Macro BiologicsDec 2025GrantLead
ProtonDxDec 2025SeedLead
ScoutDec 2025GrantCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersBoston, Massachusetts
Year Founded2016

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.